Data Acquisition Study for a Communication Device for Pediatric Patients With Cerebral Palsy
NCT ID: NCT02242994
Last Updated: 2016-12-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5 participants
INTERVENTIONAL
2014-03-31
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dynavox Maestro and Experimental App
Receives both Experimental App and Dynavox Maestro to communicate. Each participant will receive both devices. Order of device received is randomly assigned.
Dynavox Maestro
Receives commercially available communication device Dynavox Maestro to test speed and quality of communication.
Experimental App
Participant receives experimental app to test speed and error rate of communication.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dynavox Maestro
Receives commercially available communication device Dynavox Maestro to test speed and quality of communication.
Experimental App
Participant receives experimental app to test speed and error rate of communication.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* been diagnosed with spastic or dystonic diplegic or quadriplegic cerebral palsy.
* are able to communicate through written words
* are able to follow a 3- steps directions, and follow study directions and procedures.
Exclusion Criteria
7 Years
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Axel Krieger
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Axel Krieger
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's National
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00003767
Identifier Type: -
Identifier Source: org_study_id